Table 2.
PLS-DA classification results of TNBC, ER, PgR and HER-2 status
| Total b/p | NEG b/p | POS b/p | CV accuracy % | CV Sensitivity % | CV Specificity % | Permutation p-value | |
|---|---|---|---|---|---|---|---|
| TNBC vs TPBC | 39/30 | 26/19 | 13/11 | 77.7 | 80.0 | 75.4 | 0.001 |
| ERneg vs ERpos | 106/73 | 41/30 | 65/43 | 72.2 | 76.0 | 68.5 | <0.001 |
| PgRneg vs PgRpos | 106/73 | 59/42 | 47/31 | 67.8 | 74.0 | 61.6 | <0.001 |
| HER-2neg vs HER-2pos | 106/73 | 66/43 | 40/30 | 69.1 | 70.2 | 68.0 | <0.001 |
b = biopsies/p = patients. PLS-DA: partial least squares discriminant analysis, CV: cross validation.